−0.289EUR
−3.48 MEUR
7.93 M
About BBS-BIOACTIVE BONE SUBSTITUTES
Sector
Industry
CEO
Juliusz Rakowski
Website
Headquarters
Oulu
Employees (FY)
22
ISIN
FI4000260583
FIGI
BBG00JXMR9G7
BBS-Bioactive Bone Substitutes Plc is a health technology company. The firm engages in the development, research, production and manufacture of bioactive bone substitute implants. Its orthobiological product, ARTEBONE, is made of long bones of reindeers that have a superior capability for bone regeneration compared to existing allograft products. The company was founded by Pekka Kalevi Aleksanteri Jalovaara in 2003 and is headquartered in Oulu, Finland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BONEH is 0.480 EUR — it has decreased by 2.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BBS-BIOACTIVE BONE SUBSTITUTES stocks are traded under the ticker BONEH.
BBS-BIOACTIVE BONE SUBSTITUTES is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
BONEH stock is 3.59% volatile and has beta coefficient of 2.32. Check out the list of the most volatile stocks — is BBS-BIOACTIVE BONE SUBSTITUTES there?
One year price forecast for BBS-BIOACTIVE BONE SUBSTITUTES has a max estimate of 0.500 EUR and a min estimate of 0.500 EUR.
BONEH earnings for the last quarter are −0.08 EUR whereas the estimation was −0.13 EUR which accounts for 40.85% surprise. Estimated earnings for the next quarter are −0.10 EUR. See more details about BBS-BIOACTIVE BONE SUBSTITUTES earnings.
Yes, you can track BBS-BIOACTIVE BONE SUBSTITUTES financials in yearly and quarterly reports right on TradingView.
BONEH stock has fallen by 1.03% compared to the previous week, the month change is a 4.00% fall, over the last year BBS-BIOACTIVE BONE SUBSTITUTES has showed a 37.59% decrease.
BONEH net income for the last quarter is −1.84 M EUR, while the quarter before that showed −1.64 M EUR of net income which accounts for −12.18% change. Track more BBS-BIOACTIVE BONE SUBSTITUTES financial stats to get the full picture.
Today BBS-BIOACTIVE BONE SUBSTITUTES has the market capitalization of 10.39 M, it has increased by 5.88% over the last week.
No, BONEH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BONEH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BBS-BIOACTIVE BONE SUBSTITUTES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 22.00 employees. See our rating of the largest employees — is BBS-BIOACTIVE BONE SUBSTITUTES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BBS-BIOACTIVE BONE SUBSTITUTES technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BBS-BIOACTIVE BONE SUBSTITUTES stock shows the sell signal. See more of BBS-BIOACTIVE BONE SUBSTITUTES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BBS-BIOACTIVE BONE SUBSTITUTES future price: according to them, BONEH price has a max estimate of 0.50 EUR and a min estimate of 0.50 EUR. Read a more detailed BBS-BIOACTIVE BONE SUBSTITUTES forecast: see what analysts think of BBS-BIOACTIVE BONE SUBSTITUTES and suggest that you do with its stocks.